These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22326346)

  • 1. Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates.
    Saridaki T; Zampagni M; Mannini B; Evangelisti E; Taddei N; Cecchi C; Chiti F
    J Mol Biol; 2012 Aug; 421(4-5):616-30. PubMed ID: 22326346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state.
    Campioni S; Mannini B; López-Alonso JP; Shalova IN; Penco A; Mulvihill E; Laurents DV; Relini A; Chiti F
    J Mol Biol; 2012 Dec; 424(3-4):132-49. PubMed ID: 23041425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N.
    Tatini F; Pugliese AM; Traini C; Niccoli S; Maraula G; Ed Dami T; Mannini B; Scartabelli T; Pedata F; Casamenti F; Chiti F
    Neurobiol Aging; 2013 Sep; 34(9):2100-9. PubMed ID: 23601807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity.
    Mannini B; Mulvihill E; Sgromo C; Cascella R; Khodarahmi R; Ramazzotti M; Dobson CM; Cecchi C; Chiti F
    ACS Chem Biol; 2014 Oct; 9(10):2309-17. PubMed ID: 25079908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes.
    Farrugia MY; Caruana M; Ghio S; Camilleri A; Farrugia C; Cauchi RJ; Cappelli S; Chiti F; Vassallo N
    Sci Rep; 2020 Oct; 10(1):17733. PubMed ID: 33082392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
    Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.
    Ahmad B; Winkelmann J; Tiribilli B; Chiti F
    Biochim Biophys Acta; 2010 Jan; 1804(1):223-34. PubMed ID: 19836473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid formation from HypF-N under conditions in which the protein is initially in its native state.
    Marcon G; Plakoutsi G; Canale C; Relini A; Taddei N; Dobson CM; Ramponi G; Chiti F
    J Mol Biol; 2005 Mar; 347(2):323-35. PubMed ID: 15740744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-level expression of a folding-incompetent protein in Escherichia coli: search for the molecular determinants of protein aggregation in vivo.
    Winkelmann J; Calloni G; Campioni S; Mannini B; Taddei N; Chiti F
    J Mol Biol; 2010 May; 398(4):600-13. PubMed ID: 20346957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations.
    Cappelli S; Penco A; Mannini B; Cascella R; Wilson MR; Ecroyd H; Li X; Buxbaum JN; Dobson CM; Cecchi C; Relini A; Chiti F
    Biol Chem; 2016 May; 397(5):401-15. PubMed ID: 26812789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of cells exposed to prefibrillar aggregates of HypF-N.
    Magherini F; Pieri L; Guidi F; Giangrande C; Amoresano A; Bucciantini M; Stefani M; Modesti A
    Biochim Biophys Acta; 2009 Aug; 1794(8):1243-50. PubMed ID: 19409514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational properties of the aggregation precursor state of HypF-N.
    Campioni S; Mossuto MF; Torrassa S; Calloni G; de Laureto PP; Relini A; Fontana A; Chiti F
    J Mol Biol; 2008 Jun; 379(3):554-67. PubMed ID: 18466920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of α-helical structure in partially unfolded HypF-N does not affect its aggregation propensity.
    Ahmad B; Vigliotta I; Tatini F; Campioni S; Mannini B; Winkelmann J; Tiribilli B; Chiti F
    Protein Eng Des Sel; 2011 Jul; 24(7):553-63. PubMed ID: 21518735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases.
    Evangelisti E; Cascella R; Becatti M; Marrazza G; Dobson CM; Chiti F; Stefani M; Cecchi C
    Sci Rep; 2016 Sep; 6():32721. PubMed ID: 27619987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of osmolytes on the fibrillation of HypF-N.
    Bhavsar RD; Prasad S; Roy I
    Biochimie; 2013 Nov; 95(11):2190-3. PubMed ID: 23911865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
    Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
    Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of polyethylenimine-mediated DNA delivery: free carrier helps to overcome the barrier of cell-surface glycosaminoglycans.
    Hanzlíková M; Ruponen M; Galli E; Raasmaja A; Aseyev V; Tenhu H; Urtti A; Yliperttula M
    J Gene Med; 2011 Jul; 13(7-8):402-9. PubMed ID: 21721076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between Al(3+) -induced thermal stability and inhibition of fibrillation of N-terminal domain of the hydrogenase maturation factor.
    Sutariya NM; Prasad S; Athavale DA; Bhavsar RD; Roy I
    Biofactors; 2013; 39(6):597-607. PubMed ID: 23868703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefibrillar amyloid aggregates could be generic toxins in higher organisms.
    Baglioni S; Casamenti F; Bucciantini M; Luheshi LM; Taddei N; Chiti F; Dobson CM; Stefani M
    J Neurosci; 2006 Aug; 26(31):8160-7. PubMed ID: 16885229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing molecular mechanisms appear to underlie early toxicity of prefibrillar HypF-N aggregates to different cell types.
    Cecchi C; Pensalfini A; Baglioni S; Fiorillo C; Caporale R; Formigli L; Liguri G; Stefani M
    FEBS J; 2006 May; 273(10):2206-22. PubMed ID: 16649997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.